Discriminative stimulus properties of α-ethyltryptamine (α-ET) in rats: α-ET-like effects of MDMA, MDA and aryl-monomethoxy substituted derivatives of α-ET.
Carmen Abate, Richard Young, Małgorzata Dukat, Richard A Glennon
Psychopharmacology June 1, 2025 DOI: 10.1007/s00213-024-06738-y via PubMed
Summary
AI-generated from the abstractThe drug α-ethyltryptamine (α-ET), once used as an antidepressant and structurally related to the hallucinogen α-methyltryptamine, produces stimulus effects in rats that are similar to those of the phenylalkylamines MDMA (Ecstasy) and MDA (Love Drug). Rats trained to discriminate α-ET from saline showed full generalization to both MDMA and MDA. Four synthetic analogs of α-ET produced varied results: 4-OMe α-ET showed negligible α-ET-like effects, 5-OMe α-ET modest effects, while 6-OMe α-ET and 7-OMe α-ET fully generalized but with a narrow dose range for the former. α-ET appears to exert a complex stimulus combining features of MDMA, MDA, hallucinogens, and stimulants, suggesting it is a tryptamine counterpart to these phenylalkylamines.
Study at a glance
| Characteristics | Drug discrimination study Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | α-ethyltryptamine MDMA MDA 4-OMe α-ET 5-OMe α-ET 6-OMe α-ET 7-OMe α-ET |
| Dose | 2.5 mg/kg α-ET training dose; ED50 values: α-ET 1.04 mg/kg, MDMA 0.72 mg/kg, MDA 0.48 mg/kg, 6-OMe α-ET 6.26 mg/kg, 7-OMe α-ET 2.78 mg/kg |
| Topics | PTSD |
| Keywords | Drug discrimination Entactogen Phenylalkylamine Stimulant |
| Citations | 2 |
| Key finding | α-ET stimulus effects generalize to MDMA and MDA, and its monomethoxy analogs produce varied α-ET-like outcomes, indicating a complex stimulus profile. |
Abstract
Rationale α-ET (α-ethyltryptamine), a homolog of the classical hallucinogen α-methyltryptamine, was once prescribed clinically as an antidepressant. Classical psychedelic drugs are currently of interest as potential pharmacotherapy for psychiatric disorders. Objectives Drug discrimination was used to (a) determine if α-ET-like stimulus effects could be engendered by the prototypical phenylalkylamines MDMA ("Ecstasy") or MDA ("Love Drug") and (b) evaluate the α-ET-like stimulus effects of four synthesized aryl-substituted monomethoxy analogs of α-ET (4-OMe-, 5-OMe-, 6-OMe- and 7-OMe-α-ET). Methods Rats were trained to discriminate α-ET (2.5 mg/kg) from saline using a two-lever operant task. Results The α-ET (ED50 = 1.04 mg/kg) stimulus generalized to MDMA (ED50 = 0.72 mg/kg) and MDA (ED50 = 0.48 mg/kg). The four α-ET derivatives produced various results; 4-OMe α-ET yielded negligible (20% maximum) α-ET-like responding; 5-OMe α-ET occasioned a modest level (40% maximum) of α-ET-like substitution; 6-OMe α-ET (ED50 = 6.26 mg/kg) generalized completely, but in a narrow dose range and in an inverted U-shaped manner; 7-OMe α-ET (ED50 = 2.78 mg/kg) generalized completely. Conclusions α-ET stimulus effects are similar to those of MDMA, but appear more closely aligned to those of MDA and are produced by its stereoisomers which, when combined, exert MDA/MDMA-, hallucinogen- and some stimulant-like stimulus actions. Thus, α-ET exerts a complex (compound) stimulus and appears to be a tryptamine counterpart of these prototypic phenylalkylamines. The monomethoxy analogs of α-ET produced an assortment of α-ET-like outcomes such that future investigations of these agents will likely need to be performed on an individual basis; extrapolations of α-ET-like effects to these analogs should be done judiciously.